338
Participants
Start Date
September 15, 2021
Primary Completion Date
June 14, 2023
Study Completion Date
September 1, 2027
Abatacept
Abatacept SC (125 mg) once weekly
Adalimumab
Adalimumab SC (40 mg) once every 2 weeks
Methotrexate
Methotrexate oral/parenteral maximum tolerated dose (minimum 15 mg and maximum 25 mg weekly)
Local Institution - 0099, Córdoba
Local Institution - 0104, New Taipei City
Local Institution - 0095, Taichung
Local Institution - 0120, Tainan City
Local Institution - 0022, Buenos Aires
Local Institution - 0023, Buenos Aires
Local Institution - 0015, Buenos Aires
Local Institution - 0014, San Isidro
Local Institution - 0016, Quilmes
Local Institution - 0072, Botany
Local Institution - 0062, Paramatta
Local Institution - 0105, Ivanhoe
Local Institution - 0064, Camberwell
Local Institution - 0065, Geelong
Local Institution - 0049, Basel
Local Institution - 0063, Maroochydore
Local Institution - 0102, Woodville South
Local Institution - 0052, Sankt Gallen
Local Institution - 0059, Berlin
NYU Langone Ambulatory Care Brooklyn Heights, Brooklyn
Local Institution - 0006, Mexico City
Local Institution - 0025, Prague
Local Institution - 0008, Mexico City
Local Institution - 0004, A Coruña
Local Institution - 0031, Duncansville
Local Institution - 0053, Hamburg
Local Institution - 0058, Cumberland
Local Institution - 0038, Hagerstown
Local Institution - 0077, Pavia
Local Institution - 0003, Madrid
Local Institution - 0082, Wilmington
Local Institution - 0009, Chihuahua City
Local Institution - 0002, Toulouse
Local Institution - 0001, Montpellier
Local Institution - 0034, Jackson
Local Institution - 0085, Santander
Local Institution - 0096, Taichung
Local Institution - 0017, Guadalajara
Local Institution - 0117, Guadalajara
Local Institution - 0055, Bonn
Local Institution - 0119, Milwaukee
Local Institution - 0084, Eagan
Local Institution - 0035, Strasbourg
Local Institution - 0044, Dallas
Local Institution - 0047, Rouen
Local Institution - 0118, San Luis Potosí City
Local Institution - 0091, Freiburg im Breisgau
Local Institution - 0041, Aurora
Local Institution - 0056, Planegg
Local Institution - 0098, Kaohsiung Niao Sung Dist
Local Institution - 0086, Los Alamitos
Local Institution - 0036, Fullerton
Local Institution - 0083, Catania
Local Institution - 0005, Mérida
Local Institution - 0127, Portland
Local Institution - 0010, Tokyo
Local Institution - 0040, Freehold
Local Institution - 0012, CABA
Local Institution - 0057, San Miguel de Tucumán
Local Institution - 0028, Brno
Local Institution - 0078, Perugia
Local Institution - 0100, Roma
Local Institution - 0093, Nagoya
Local Institution - 0079, Kitakyushu
Local Institution - 0110, Sapporo
Local Institution - 0046, Sendai
Local Institution - 0112, Sasebo
Local Institution - 0090, Kawagoe
Local Institution - 0089, Tokyo
Local Institution - 0020, Torun
Local Institution - 0124, Bydgoszcz
Local Institution - 0019, Elblag
Local Institution - 0111, Cannock
Local Institution - 0060, Hull
Local Institution - 0114, London
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY